InSilico Medicine Cayman TopCo
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 3696.HK | 688202.SS | 1FW1.F | ROIV | CAI | 3759.HK | |
|---|---|---|---|---|---|---|
| Market cap | 22.80B | 10.63B | 22.64B | 27.61B | 9.39B | 55.85B |
| P/E (TTM) | — | — | 37.9 | — | 19.7 | 27.4 |
| Forward P/E | 22.6 | 35.8 | — | -27.5 | 89.3 | 17.2 |
| Price/book | 5.3 | 5.2 | 3.5 | 6.5 | 16.3 | 2.8 |
| Dividend yield | — | — | — | — | — | 0.78% |
| 1-year change | +31.35% | +15.42% | +44.16% | +85.85% | +34.99% | +19.72% |
| Today | 0.00% | +2.00% | −0.90% | +6.08% | +1.13% | +3.47% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 3696.HK news ›InSilico Medicine Cayman TopCo Triggers A Milestone Payment In AI-Driven R&D Collaboration With Servier For Achieving Early Drug Discovery Milestone
InSilico Medicine Cayman TopCo achieved the early drug discovery milestone in its multi-year AI-driven drug discovery collaboration with Servier. First announced in early 2026, the multi-year research... InSilico Medicine Cayman TopCo…
InSilico Medicine Cayman TopCo Stock (3696) - Quote Hong Kong S.E.
InSilico Medicine Cayman TopCo is a company principally engaged in the artificial intelligence (AI)-driven drug discovery and pipeline development business. The Company mainly self-develops drug candidates, co-develops and partially…
InSilico Medicine Cayman TopCo Nominates Peripheral-Restricted VAV1 Molecular Glue Degrader for Potential Treatment of Autoimmune Diseases
InSilico Medicine Cayman TopCo nominated ISM9546, an innovative, orally bioavailable, peripheral-restricted VAV1 molecular glue degrader, as a preclinical candidate for the potential treatment of... InSilico Medicine Cayman TopCo nominated…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.